Key Points
Founded in 2006, its best known as a genetic testing company that provides insights into peoples ancestry and health risks from tubes of spit they send through the mail...
Its also a data company, having amassed a trove of DNA samples from some 10 million people who have consented to sharing their genetic information for research..
Wojcicki has saved 23andMe from the brink of failure beforenotably after the US Food and Drug Administration ordered the company in 2013 to stop marketing its health risk assessments to customers until the business could validate them, which took several years..
But a decade later, the challenges are bigger and the solutions less clear: 23andMe needs to rebuild trust after its data breach, convince customers that it is a subscriptions business, and find new investors and industry partners to support its forays into drug development...
Were 17 years old, data privacy and security has always been a really high priority and remains a high priority for the company and something that we are going to invest even more into.. 23andMe is also involved in drug development..
